Functional Medicine Health Coaching

Sponsor
The Institute for Functional Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT05551546
Collaborator
Functional Medicine Coaching Academy (Other)
150
1
2
2.1
70.2

Study Details

Study Description

Brief Summary

The goal of this research is to evaluate the feasibility and self-reported health outcomes of functional medicine health coaching in elimination diets among clinicians receiving training in functional medicine.

A randomized controlled clinical trial of a 5-session functional medicine coaching and elimination diet intervention will be conducted to achieve the purpose of this study. The research team hypothesizes that functional medicine health coaching to support the elimination diet will improve physical and mental health outcomes better than the control condition of a self-guided elimination diet.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Functional Medicine Health Coaching for Elimination Diet for Elimination Diet
  • Behavioral: Self-guided Elimination Diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Effect of Functional Medicine Health Coaching on Self-Reported Measures of Physical and Emotional Health: A Randomized Controlled Trial.
Actual Study Start Date :
Sep 26, 2022
Actual Primary Completion Date :
Nov 30, 2022
Actual Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Functional Medicine Health Coaching for Elimination Diet

Participants randomized into the "Functional Medicine Health Coaching for Elimination Diet" arm will receive five remote health coaching sessions over 10 weeks in support of their progress through an elimination diet. All study arms will receive written elimination diet support materials.

Behavioral: Functional Medicine Health Coaching for Elimination Diet for Elimination Diet
All participants will receive 5 coaching sessions to support them through the elimination diet. First session: The foundation session is where the coach and participant begin to develop rapport and outline the participant's goals. This occurs before the start of the Elimination Diet for motivation, expectations, education, and preparation. Second session: This can occur during week 1 of the elimination diet to support working through the implementation. Third session: This session is recommended to occur during week 3 of the diet to prepare for the reintroduction of foods. Fourth session: A session is recommended while the participant is reintroducing foods as this is typically the most difficult part of the diet as participants may be experiencing symptoms to reactive foods. Fifth session: A wrap up session is recommended after all of the food re-introductions to support the participant with maintenance, goals to move forward, and reflection.

Other: Self-guided Elimination Diet

Participants randomized into the "Self-guided Elimination Diet" group will engage with the elimination diet without health coaching. All study arms will receive written elimination diet support materials.

Behavioral: Self-guided Elimination Diet
The Elimination Diet course materials include self-guided materials designed to guide participants through all phases of a comprehensive elimination diet, including preparation, elimination, and reintroduction phases. All participants in this wait-list control group will be presented via email with the opportunity to receive the five sessions of coaching (described above) at the conclusion of the study.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline PROMIS-Global Health score [Change from baseline at 10 weeks]

    The PROMIS Global Health is a 10-item survey (PROMIS-10) is measure of health status that spans physical, mental, and social domains from the patient perspective, allowing clinicians and researchers to capture the complex and heterogeneous nature of the populations.

Secondary Outcome Measures

  1. Change from baseline Medical Symptoms Questionnaire (MSQ) score [Change from baseline at 10 weeks]

    The Medical Symptoms Questionnaire is a multi-system inventory that rates symptom severity on a 0-4 scale. The MSQ has been used to track subjective responses of patients to treatment in both clinical and research settings.

  2. Adherence/compliance to the elimination diet [At 10 weeks]

    The Adherence/compliance assessment is a 0-10 scale that asks the participant one question to self-rate how well they followed the Elimination Diet. This has been used in the Healthy Diet and Lifestyle Study pilot, a randomized trial.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Agree to adopt the elimination diet as outlined by study sponsor with no pre-planned interruption

  • Able to understand and write English

  • Voluntarily consent to the study and understand its nature and purpose including potential risks and side effects

Exclusion Criteria:
  • Eating disorders within the past 10 years

  • Currently pregnant or breastfeeding

  • Nursing home residents, other institutionalized persons, prisoners, any other vulnerable participants

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Institute for Functional Medicine Federal Way Washington United States 98003

Sponsors and Collaborators

  • The Institute for Functional Medicine
  • Functional Medicine Coaching Academy

Investigators

  • Principal Investigator: Sandra Scheinbaum, PhD, Functional Medicine Coaching Academy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Institute for Functional Medicine
ClinicalTrials.gov Identifier:
NCT05551546
Other Study ID Numbers:
  • EliminationDietRCT1
First Posted:
Sep 22, 2022
Last Update Posted:
Dec 2, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Dec 2, 2022